Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination

Cureus. 2022 Jun 28;14(6):e26383. doi: 10.7759/cureus.26383. eCollection 2022 Jun.

Abstract

Vaccination has made a substantial contribution to global health improvement throughout history. The coronavirus disease 2019 (COVID-19) vaccinations have provided us with a ray of hope for combatting the ongoing pandemic and saving lives. However, following COVID-19 vaccination, a wide spectrum of cutaneous adverse effects have been observed. We report a case of dyshidrosiform bullous pemphigoid, a rare clinical variant of bullous pemphigoid, following COVID-19 vaccination in an elderly female patient. The biopsy revealed subepidermal splitting with positive direct and indirect immunofluorescence studies.

Keywords: bullous pemphigoid; covid 19; covid-19 vaccination; covid-19 vaccination skin side effects; dyshidrosiform bullous pemphigoid.

Publication types

  • Case Reports